Symptomatic relief of bronchospasm associated w/ acute severe exacerbations of bronchial asthma or COPD.
Dosage/Direction for Use
Iperol Elderly, adult & adolescent >12 yr 1 mL up to 2-4 mL in severe cases. Childn 6-12 yr 0.5-1 mL up to 2-3 mL in severe cases,<6 yr 0.1 mL/kg/dose up to 0.5 mL up to tid. Intermittent & long-term treatment: Elderly, adult & adolescent >12 yr 1-2 mL up to qid. Childn 6-12 yr 0.5-1 mL up to qid. Iperol ForteAdult & childn >12 yrAcute asthma episodes 1 UDV. 2 UDV in very severe cases. Intermittent & long-term treatment: 1 UDV up to qid.
Hypersensitivity to atropine-like substances. Hypertrophic obstructive cardiomyopathy, tachyarrhythmia.
Patients w/ prostatic hypertrophy or bladder-neck obstruction or predisposed to narrow-angle glaucoma. Pregnancy & lactation. Childn <12 yr (Iperol Forte).
Fine tremor of skeletal muscles, nervousness & dryness of the mouth; headache, dizziness, tachycardia & palpitations, hypokalemia, eye pain or discomfort, blurred vision, signs of acute narrow-angle glaucoma eg, visual halos or colored images associated w/ red eyes from conjunctival & corneal congestion.
R03AL01 - fenoterol and ipratropium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.